DataString Consulting Company Logo
DataString Consulting Company Logo
Liposome Market
Request Free Sample
Home»Recent Reports»Liposome Market

Liposome Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1904025, Published - June 2025

Segmented in Product Classification (Liposomal Drug Delivery, Liposomal Nutrition Supplements, Liposomal Skin Care), Application (Pharmaceutical, Personal Care & Cosmetics, Nutraceuticals, Others), Formulation Composition, Packaging, Distribution Channels and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Liposome Market Outlook

The market, for Liposome was estimated at $2.7 billion in 2024; and it is anticipated to increase to $5.9 billion by 2030 with projections indicating a growth to around $11.5 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 14.0% over the forecast period. The rise in the Liposome market can be linked to important factors driving its growth momentum today. The sectors growth is mainly fueled by the growing number of illnesses that demand efficient drug delivery systems and the increased investments in research and development. Additionally the ongoing advancements in pharmaceutical and biotechnological approaches play a role in driving this expansion. Furthermore Liposomes are gaining importance, in targeted drug delivery applications, which is attracting interest from the healthcare and pharmaceutical sectors worldwide. The growing demand, for these carriers stems from their capacity to contain both water loving and water repelling medications effectively while also lowering the toxicity of drugs and enhancing their effectiveness in treatment.


Tiny spherical structures called liposomes are made up of a layer of phospholipids and have been modified significantly to be used in innovative methods of delivering medications. They show a flexibility in their capacity to enclose various substances with different sizes and physical characteristics which makes them perfect choices for transporting healing substances. Common uses of liposomes involve treatments for cancer prevention and management well as gene therapy procedures along, with vaccinations and medical testing purposes.


Market Size Forecast & Key Insights

2019
$2.7B2024
2029
$10B2034

Absolute Growth Opportunity = $7.3B

•The Liposome market is projected to grow from $2.7 billion in 2024 to $10.0 billion in 2034. This represents a CAGR of 14.0%, reflecting rising demand across Drug Delivery Systems, Food & Nutrition and Cosmetics & Personal Care.

•The Liposome market is set to add $7.3 billion between 2024 and 2034, with manufacturer targeting Personal Care & Cosmetics & Nutraceuticals Application projected to gain a larger market share.

•With The rise of targeted drug delivery systems, and Nanotechnology in cosmetics, Liposome market to expand 271% between 2024 and 2034.

Opportunities in the Liposome Market

Strategic Partnerships for Technological Innovations

Advancements, in liposome technology are constantly progressing; creating collaborations can help accelerate innovation and broaden market penetration.

Leveraging the Power of Liposomes in Drug Delivery and Untapped Market Potential in Emerging Economies

With the progress made in liposomal technology advancements in the field have provided a pathway to enhance the effectiveness of drugs and diminish their side effects significantly. The distinctive composition of liposomes allows them to serve as carriers for medications a development that shows great potential in creating targeted drug delivery systems. Encapsulating drugs within liposomes can result in performance reducing harm to healthy cells while maximizing their therapeutic impact, on affected areas. This advancement benefits patients and pharmaceutical companies alike by enhancing adherence and potentially boosting profit margins.

Emerging economies like India and China are experiencing progress in healthcare infrastructure and higher investments in research and development activities These advancements hold great potential for liposomal products as the prevalence of chronic diseases continues to rise and there is a growing need for effective treatments in these areas By strategically entering these markets companies can access a large consumer base and take advantage of being early entrants, to the market.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

The Asia-Pacific region presents significant opportunities for the liposome market, with an emphasis on emerging economies like India, China, and Japan. Widespread applications of liposome extend to drug delivery systems, particularly in cancer treatment. Driven by expanding pharmaceutical and biopharmaceutical industries, these countries offer a fertile ground for liposome-based research. Key competitors such as Sun Pharma and Takeda Pharmaceuticals are instrumental in integrating liposome technology into their product pipeline. Governmental initiatives encouraging nanotechnology research contribute towards the enhancement of liposome technology within the healthcare sector.

North America Outlook

In North America, the demand for Liposome technology is driven by the pharmaceuticalindustry'sinnovative drive, with key players focusing on liposomal drug delivery. Liposomes cater to multiple applications in targeted therapy, diagnostic imaging, and vaccine development sectors, becoming the epicenter for major research and development initiatives. The defining competitive landscape is marked by the existence of key market players like Gilead Sciences, Johnson & Johnson, and Pfizer, who actively use liposome technology in product development, thereby further intensifying the demand. A bolstering factor for liposome advancements in this region is the continuing support from government bodies for research in nanotechnology and biotechnology. Distinctive market expansion is fueled by increased healthcare spending and a rising aging population that demands improved diagnostic and therapeutic procedures.

North America Outlook

In North America, the demand for Liposome technology is driven by the pharmaceuticalindustry'sinnovative drive, with key players focusing on liposomal drug delivery. Liposomes cater to multiple applications in targeted therapy, diagnostic imaging, and vaccine development sectors, becoming the epicenter for major research and development initiatives. The defining competitive landscape is marked by the existence of key market players like Gilead Sciences, Johnson & Johnson, and Pfizer, who actively use liposome technology in product development, thereby further intensifying the demand. A bolstering factor for liposome advancements in this region is the continuing support from government bodies for research in nanotechnology and biotechnology. Distinctive market expansion is fueled by increased healthcare spending and a rising aging population that demands improved diagnostic and therapeutic procedures.

Asia-Pacific Outlook

The Asia-Pacific region presents significant opportunities for the liposome market, with an emphasis on emerging economies like India, China, and Japan. Widespread applications of liposome extend to drug delivery systems, particularly in cancer treatment. Driven by expanding pharmaceutical and biopharmaceutical industries, these countries offer a fertile ground for liposome-based research. Key competitors such as Sun Pharma and Takeda Pharmaceuticals are instrumental in integrating liposome technology into their product pipeline. Governmental initiatives encouraging nanotechnology research contribute towards the enhancement of liposome technology within the healthcare sector.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : U.S., Germany, UK, Japan, China are expected to grow at 12.6% to 16.8% CAGR

2

Emerging Markets : India, Brazil, South Africa are expected to grow at 9.8% to 14.7% CAGR

Market Analysis Chart

The Liposome market has experienced significant growth due to several drivers that have come into play in recent years. One of the most prominent drivers is the increasing prevalence of various infectious diseases and cancers, increasing the demand for advanced drug delivery systems. Liposomes, with their ability to encapsulate both hydrophilic and hydrophobic drugs, have played a crucial role in this surge.

Recent Developments and Technological Advancement

December 2024

Leading pharmaceutical giant Pfizer Inc. innovated its cancer research with the development of Liposome-based drug delivery systems, ensuring optimized drug targeting and reduced side effects

October 2024

Nanbiosis, an acclaimed producer of nanoparticles and nanocomposites, launched a new line of Liposome-, specifically designed to enhance skincare products by facilitating active ingredient penetration

August 2024

Johnson & Johnson stepped forward in Liposome technology, formulating a novel Liposome-enriched vaccine for faster and more effective immunization.

Understanding the market dynamics of Liposome - a drug-delivery system that encapsulates medication, bioactive molecules, or vaccines in a lipid bilayer - is critical, especially in the context of recent global health challenges. Advances in the healthcare industry, accelerated by the pandemic, have seen Liposomes being increasingly used in pharmaceutical and cosmetic products due to its ability to enhance absorption and bioavailability.

Impact of Industry Transitions on the Liposome Market

As a core segment of the F&B Technology industry, the Liposome market develops in line with broader industry shifts. Over recent years, transitions such as The Accelerated Emergence of Drug Delivery Systems and The Surge in Cosmetics Utilization have redefined priorities across the F&B Technology sector, influencing how the Liposome market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

The Accelerated Emergence of Drug Delivery Systems:

The pharmaceutical sector has long been a major benefactor of liposome technology. Liposomes unique characteristics, such as biocompatibility and the ability to encapsulate both hydrophobic and hydrophilic compounds, have made them an ideal solution for targeted drug delivery. Through liposome, drug efficacy is increased while minimizing systemic side effects. Cited evidence of this transitions impact is particularly evident in oncology, where liposomal drugs like Doxil and Lipodox have revolutionized chemotherapy treatment methods, improving patient outcomes significantly

2

The Surge in Cosmetics Utilization:

As the global cosmetics industry evolves, the use of liposome technology has been a consequential transition. Liposomes have been integrated into a multitude of skincare products owing to their ability to enhance the delivery of active ingredients deep into the skin layers. This ensures heightened efficacy and also increases product quality.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the F&B Technology industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the F&B Technology industry cascade into the Liposome market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: The Rise of Targeted Drug Delivery Systems, and Growth in Biomedical Research

The field of specialty pharmaceuticals is also showing a growing interest in utilizing liposome technology for delivering drugs to locations within the body more effectively and efficiently. This is also because liposomes are also known for being non toxic vesicles that can also degrade naturally in the body making them perfect, for targeted drug delivery purposes. Furthermore liposomes have also the ability to encapsulate drugs with solubilities resulting in an increased therapeutic index and a lower risk of potential side effects.
Advancements in biomedical research have also uncovered diverse applications of liposomes. They are also being used extensively for encapsulating genetic material in gene therapy, enhancing the delivery of vaccines, and even serving as adjuvants. Liposome technologys flexibility to incorporate hydrophilic and hydrophobic agents effectively has also made it a preferred choice in complex biomedical applications, driving the liposome markets growth.
The use of nanotechnology in the beauty industry has also led to a surge in the popularity of liposomes due to their ability to effectively reach skin cells with nourishing ingredients through their nano sized vesicles technology in cosmetics like moisturizers and anti wrinkle products for lasting effects, on the skins surface layer.

Restraint: High Production Cost

The creation of liposomes requires procedures and cutting edge technologies implemented by a proficient workforce which leads to elevated production expenses. A crucial factor in the liposome industry landscape. The substantial costs not only drive up the prices of products but also hinder accessibility for various consumers thereby adversely affecting market demand. This challenge compounded by limitations, in emerging nations further constrains the growth potential of the liposome market.

Challenge: Regulatory Challenges

Liposomes have garnered a lot of attention in the pharmaceutical and biotechnology sectors due to their potential therapeutic implications. Despite this, the market for liposomes faces regulatory restrictions and stringent approval processes, especially concerning their use in therapeutics and drug delivery systems. This hurdle not only slows down the timeliness of new product launches but also affects overall market dynamics, with potential drugs stuck in the pipeline. Consequently, market growth may not only reach its predicted potential due to these regulatory constraints.

Supply Chain Landscape

Raw Material Suppliers

Avanti Polar Lipids Inc

Lipoid GmbH

Manufacturing & Production

Northern Lipids Inc

Creative Biostructure

Distribution & Intermediate Users
Medizone International Inc / NanoCove L.L.C
End Users
Pharmaceutical / Cosmetics / Nutraceutical
Raw Material Suppliers

Avanti Polar Lipids Inc

Lipoid GmbH

Manufacturing & Production

Northern Lipids Inc

Creative Biostructure

Distribution & Intermediate Users

Medizone International Inc

NanoCove L.L.C

End Users

Pharmaceutical

Cosmetics

Nutraceutical

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Drug Delivery
Pharmaceutical
Spectrum Pharmaceuticals
Focused on the development of liposome-encapsulated drugs to target cancer cells specifically
Therapeutics
Biotechnology
Johnson & Johnson
Innovation in liposomal formulation to enhance therapeutic effects of drugs with minimal side-effects
Skincare
Cosmetics
L'Oreal
Incorporating liposomes for better skin product absorption and increased efficacy
Vaccines
Healthcare
Pfizer
Using liposome technology for developing stable, effective, and safe vaccines for various diseases

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Liposome market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Liposome in Cosmetics & Personal Care and Food & Nutrition and Drug Delivery Systems

Cosmetics & Personal Care and Food & Nutrition

Liposome technology is widely applied in the cosmetics and personal care industry owing to its ability to improve the delivery of active ingredients to the skin. Liposomes, especially phospholipid liposomes, act as powerful bio-carriers and enhance the penetration of various beneficial compounds into the skin. Companies such as LOreal and Estee Lauder have capitalized on the liposome technology to develop advanced skincare products with targeted benefits.



In the food and nutrition industry, liposomes are employed for the encapsulation and controlled release of health-promoting bioactive ingredients, such as vitamins, antioxidants, and omega-3 fatty acids. For food applications, non-toxic and edible liposomes are preferred.

Drug Delivery Systems

Liposomes are extensively used as drug delivery systems due to the ability to encapsulate variouss of drugs including small molecule therapeutics and genetic materials. They enhance therapeutic index by prolonging systemic circulation, improving biodistribution and increasing drug localization in pathological tissues. In the drug delivery segment, the prominent use of liposomes is found in oncology treatments, where liposome-encapsulated drugs like Doxil have proved effective in controlled drug release and reducing systemic toxicity. Key players like Johnson & Johnson and Gilead Sciences have leveraged liposome technology in this sector, displaying significant contributions to the market.

Liposome vs. Substitutes:
Performance and Positioning Analysis

Liposome stands out from its alternatives with its biocompatibility, reduced toxicity, and versatile encapsulation abilities, offering a unique promise in the pharmaceutical market with growth potential

Liposome
  • Micelles /
  • Niosomes /
  • Solid lipid nanoparticles
    •High encapsulation efficiency, ability to deliver both hydrophilic and hydrophobic drugs
    •Low stability, potential for oxidative degradation
    •Highly efficient delivery mechanism, specific targeting capabilities
    •Possible toxicity, higher production costs

Liposome vs. Substitutes:
Performance and Positioning Analysis

Liposome

  • High encapsulation efficiency, ability to deliver both hydrophilic and hydrophobic drugs
  • Low stability, potential for oxidative degradation

Micelles / Niosomes / Solid lipid nanoparticles

  • Highly efficient delivery mechanism, specific targeting capabilities
  • Possible toxicity, higher production costs

Liposome stands out from its alternatives with its biocompatibility, reduced toxicity, and versatile encapsulation abilities, offering a unique promise in the pharmaceutical market with growth potential

Loading...

Research Methodology

This market research methodology defines the Liposome market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at macro and micro levels. As part of the F&B Technology ecosystem, we analyze Liposome across Pharmaceutical, Personal Care & Cosmetics, and Nutraceuticals Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.



Key Sources Referenced:

• Food and Agriculture Organization (FAO)

• Food Substances - FDA

• Prodcom / Census US / Statcan / e-stat Japan / ABS Australia / KOSIS Korea

• USA Trade Census

• DEFRA UK / Ifastat

• Climate.gov

• Annual Reports / Industry Magazines / Country Level Ministerial Sources

We benchmark competitors such as Johnson & Johnson Services Inc., Pfizer Inc., and L'Oreal S.A. by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, Manufacturing & Production, and Distribution & Intermediate Users. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global F&B Technology revenues to estimate the Liposome segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (Avanti Polar Lipids Inc, Lipoid GmbH), Manufacturing & Production (Northern Lipids Inc, Creative Biostructure), and Distribution & Intermediate Users. Our parallel substitute analysis examines Micelles, Niosomes, and Solid lipid nanoparticles, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Johnson & Johnson Services Inc., Pfizer Inc., and L'Oreal S.A., analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Liposome market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Liposome Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 3.1 billion
Revenue Forecast in 2034USD 10.0 billion
Growth RateCAGR of 14.0% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20242.7 billion
Growth OpportunityUSD 7.3 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20242.7 billion USD
Market Size 20274.0 billion USD
Market Size 20295.2 billion USD
Market Size 20305.9 billion USD
Market Size 203410.0 billion USD
Market Size 203511.5 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Classification, Application, Formulation Composition, Packaging, Distribution Channels
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledJohnson & Johnson Services Inc., Pfizer Inc., L'Oreal S.A., Encapsula BioSciences LLC, Celgene Corporation, Sanofi S.A., Astellas Pharma Inc., Indena S.p.A., Novartis International AG, Gilead Sciences Inc., Imperial Chemical Industries Ltd. and Avanti Polar Lipids Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • •Assess and prioritize high-value markets with precision
  • •Craft tailored entry and expansion roadmaps
  • •De-risk investments through rigorous market intelligence
  • •Architect dynamic pricing frameworks aligned to value creation
  • •Unlock sustainable margin enhancement opportunities
  • •Benchmark performance against global industry leaders
  • •Strategically realign portfolios to future growth drivers
  • •Accelerate commercialization of breakthrough offerings
  • •Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Liposome Market Size, Opportunities & Strategic Insights, by Product Classification

4.1Liposomal Drug Delivery
4.2Liposomal Nutrition Supplements
4.3Liposomal Skin Care
Chapter 5

Liposome Market Size, Opportunities & Strategic Insights, by Application

5.1Pharmaceutical
5.2Personal Care & Cosmetics
5.3Nutraceuticals
5.4Others
Chapter 6

Liposome Market Size, Opportunities & Strategic Insights, by Formulation Composition

6.1Phospholipid
6.2Cationic
6.3Elastic
Chapter 7

Liposome Market Size, Opportunities & Strategic Insights, by Packaging

7.1Individual packaging
7.2Bulk packaging
Chapter 8

Liposome Market Size, Opportunities & Strategic Insights, by Distribution Channels

8.1Direct Sales
8.2Online Retail
Chapter 9

Liposome Market, by Region

9.1North America Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS Liposome Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1Johnson & Johnson Services Inc.
10.2.2Pfizer Inc.
10.2.3L'Oreal S.A.
10.2.4Encapsula BioSciences LLC
10.2.5Celgene Corporation
10.2.6Sanofi S.A.
10.2.7Astellas Pharma Inc.
10.2.8Indena S.p.A.
10.2.9Novartis International AG
10.2.10Gilead Sciences Inc.
10.2.11Imperial Chemical Industries Ltd.
10.2.12Avanti Polar Lipids Inc.